• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数字关联结核病诊断技术在耐多药结核病传播实时监测中的潜在应用:检测结果的验证与分析

Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.

作者信息

Ng Kamela Charmaine, Meehan Conor Joseph, Torrea Gabriela, Goeminne Léonie, Diels Maren, Rigouts Leen, de Jong Bouke Catherine, André Emmanuel

机构信息

Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Pôle de Microbiologie Médicale, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

出版信息

JMIR Med Inform. 2018 Feb 27;6(1):e12. doi: 10.2196/medinform.9309.

DOI:10.2196/medinform.9309
PMID:29487047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5849801/
Abstract

BACKGROUND

Tuberculosis (TB) is the highest-mortality infectious disease in the world and the main cause of death related to antimicrobial resistance, yet its surveillance is still paper-based. Rifampicin-resistant TB (RR-TB) is an urgent public health crisis. The World Health Organization has, since 2010, endorsed a series of rapid diagnostic tests (RDTs) that enable rapid detection of drug-resistant strains and produce large volumes of data. In parallel, most high-burden countries have adopted connectivity solutions that allow linking of diagnostics, real-time capture, and shared repository of these test results. However, these connected diagnostics and readily available test results are not used to their full capacity, as we have yet to capitalize on fully understanding the relationship between test results and specific rpoB mutations to elucidate its potential application to real-time surveillance.

OBJECTIVE

We aimed to validate and analyze RDT data in detail, and propose the potential use of connected diagnostics and associated test results for real-time evaluation of RR-TB transmission.

METHODS

We selected 107 RR-TB strains harboring 34 unique rpoB mutations, including 30 within the rifampicin resistance-determining region (RRDR), from the Belgian Coordinated Collections of Microorganisms, Antwerp, Belgium. We subjected these strains to Xpert MTB/RIF, GenoType MTBDRplus v2.0, and Genoscholar NTM + MDRTB II, the results of which were validated against the strains' available rpoB gene sequences. We determined the reproducibility of the results, analyzed and visualized the probe reactions, and proposed these for potential use in evaluating transmission.

RESULTS

The RDT probe reactions detected most RRDR mutations tested, although we found a few critical discrepancies between observed results and manufacturers' claims. Based on published frequencies of probe reactions and RRDR mutations, we found specific probe reactions with high potential use in transmission studies: Xpert MTB/RIF probes A, Bdelayed, C, and Edelayed; Genotype MTBDRplus v2.0 WT2, WT5, and WT6; and Genoscholar NTM + MDRTB II S1 and S3. Inspection of probe reactions of disputed mutations may potentially resolve discordance between genotypic and phenotypic test results.

CONCLUSIONS

We propose a novel approach for potential real-time detection of RR-TB transmission through fully using digitally linked TB diagnostics and shared repository of test results. To our knowledge, this is the first pragmatic and scalable work in response to the consensus of world-renowned TB experts in 2016 on the potential of diagnostic connectivity to accelerate efforts to eliminate TB. This is evidenced by the ability of our proposed approach to facilitate comparison of probe reactions between different RDTs used in the same setting. Integrating this proposed approach as a plug-in module to a connectivity platform will increase usefulness of connected TB diagnostics for RR-TB outbreak detection through real-time investigation of suspected RR-TB transmission cases based on epidemiologic linking.

摘要

背景

结核病是全球致死率最高的传染病,也是与抗菌药物耐药性相关的主要死因,但其监测仍采用纸质记录。耐利福平结核病(RR-TB)是一场紧迫的公共卫生危机。自2010年以来,世界卫生组织认可了一系列快速诊断检测(RDT),这些检测能够快速检测耐药菌株并产生大量数据。与此同时,大多数高负担国家已采用连接解决方案,可实现诊断设备的连接、这些检测结果的实时获取以及共享存储。然而,这些连接的诊断设备和现成的检测结果并未得到充分利用,因为我们尚未充分利用对检测结果与特定rpoB突变之间关系的理解来阐明其在实时监测中的潜在应用。

目的

我们旨在详细验证和分析RDT数据,并提出连接诊断设备及相关检测结果在RR-TB传播实时评估中的潜在用途。

方法

我们从比利时安特卫普的比利时微生物协调保藏中心选取了107株携带34种独特rpoB突变的RR-TB菌株,其中30种在利福平耐药决定区(RRDR)内。我们对这些菌株进行了Xpert MTB/RIF、GenoType MTBDRplus v2.0和Genoscholar NTM + MDRTB II检测,并根据菌株现有的rpoB基因序列对检测结果进行了验证。我们确定了结果的可重复性,分析并可视化了探针反应,并提出将其用于评估传播的潜在用途。

结果

RDT探针反应检测出了大多数测试的RRDR突变,尽管我们发现观察结果与制造商声明之间存在一些关键差异。根据已发表的探针反应频率和RRDR突变情况,我们发现了在传播研究中具有高度潜在用途的特定探针反应:Xpert MTB/RIF探针A、B延迟、C和E延迟;GenoType MTBDRplus v2.0的WT2、WT5和WT6;以及Genoscholar NTM + MDRTB II的S1和S3。对有争议突变的探针反应进行检查可能有助于解决基因型和表型检测结果之间的不一致。

结论

我们提出了一种通过充分利用数字连接的结核病诊断设备和检测结果共享存储库来实时检测RR-TB传播的新方法。据我们所知,这是针对2016年世界著名结核病专家关于诊断连接在加速结核病消除努力方面潜力的共识所开展的第一项务实且可扩展的工作。我们提出的方法能够促进同一环境中使用的不同RDT之间的探针反应比较,这证明了该方法的有效性。将此方法作为插件模块集成到连接平台中,将通过基于流行病学关联对疑似RR-TB传播病例进行实时调查,提高连接的结核病诊断设备在RR-TB疫情检测中的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/435a/5849801/3d3beb0fc263/medinform_v6i1e12_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/435a/5849801/41f09dff4a71/medinform_v6i1e12_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/435a/5849801/3d3beb0fc263/medinform_v6i1e12_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/435a/5849801/41f09dff4a71/medinform_v6i1e12_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/435a/5849801/3d3beb0fc263/medinform_v6i1e12_fig2.jpg

相似文献

1
Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.数字关联结核病诊断技术在耐多药结核病传播实时监测中的潜在应用:检测结果的验证与分析
JMIR Med Inform. 2018 Feb 27;6(1):e12. doi: 10.2196/medinform.9309.
2
Bridging the TB data gap: extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.弥合结核病数据差距:从全基因组序列数据中提取耐利福平结核病诊断测试结果
PeerJ. 2019 Aug 26;7:e7564. doi: 10.7717/peerj.7564. eCollection 2019.
3
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.使用 Xpert® MTB/RIF 在乌干达坎帕拉检测结核分枝杆菌临床分离株中 rpoB 基因 81bpRRDR 区的利福平耐药突变:一项回顾性研究。
BMC Infect Dis. 2014 Sep 4;14:481. doi: 10.1186/1471-2334-14-481.
4
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.在巴基斯坦开伯尔-普赫图赫瓦省使用Xpert MTB/RIF检测结核分枝杆菌临床分离株rpoB基因81bp利福平耐药决定区的利福平耐药突变:一项回顾性研究
BMC Infect Dis. 2016 Aug 12;16:413. doi: 10.1186/s12879-016-1745-2.
5
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.用于检测成人肺结核及利福平耐药性的Xpert® MTB/RIF检测法
Cochrane Database Syst Rev. 2014 Jan 21;2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3.
6
Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis.Xpert MTB/RIF检测法与GenoType MTBDRplus DNA探针检测结核分枝杆菌中利福平耐药相关突变的比较
PLoS One. 2016 Apr 7;11(4):e0152694. doi: 10.1371/journal.pone.0152694. eCollection 2016.
7
Distribution and Frequency of B Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Isolates in Bangladesh.在孟加拉国北京型和非北京型利福平耐药菌株中,采用Xpert MTB/RIF检测法检测到的B基因突变的分布及频率
Infect Drug Resist. 2020 Mar 10;13:789-797. doi: 10.2147/IDR.S240408. eCollection 2020.
8
Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria.在尼日利亚克罗斯河州,使用Xpert MTB/Rif检测结核分枝杆菌的利福平耐药性及rpoB基因突变的81bp利福平耐药决定区。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S145-S146. doi: 10.1016/j.ijmyco.2016.09.007. Epub 2016 Oct 21.
9
High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia.在埃塞俄比亚亚的斯亚贝巴,GeneXpert MTB/RIF 检测呈阳性的肺结核病例中,检测到 rpoB 基因中 RR-TB 和导致 RR 的突变比例较高,且 RR 不在 RRDR 之外。
PLoS One. 2022 Dec 30;17(12):e0277145. doi: 10.1371/journal.pone.0277145. eCollection 2022.
10
Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.儿童结核病的耐药模式和突变模式:来自印度北部的研究。
Indian J Tuberc. 2021 Oct;68(4):481-484. doi: 10.1016/j.ijtb.2021.02.014. Epub 2021 Mar 2.

引用本文的文献

1
Whole genome sequencing analysis to evaluate the influence of T2DM on polymorphisms associated with drug resistance in M. tuberculosis.全基因组测序分析评估 T2DM 对与结核分枝杆菌耐药性相关的多态性的影响。
BMC Genomics. 2022 Jun 24;23(1):465. doi: 10.1186/s12864-022-08709-z.
2
Identification and Characterization of Mycobacterial Species Using Whole-Genome Sequences.基于全基因组序列鉴定和描述分枝杆菌菌种。
Methods Mol Biol. 2021;2314:399-457. doi: 10.1007/978-1-0716-1460-0_19.
3
Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review.

本文引用的文献

1
How should discordance between molecular and growth-based assays for rifampicin resistance be investigated?对于利福平耐药性,应如何研究基于分子检测和基于生长的检测之间的不一致性?
Int J Tuberc Lung Dis. 2017 Jul 1;21(7):721-726. doi: 10.5588/ijtld.17.0140.
2
Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by Xpert Mycobacterium tuberculosis/Rifampicin and Mycobacterium Growth Indicator Tube.减轻Xpert结核分枝杆菌/利福平检测法与分枝杆菌生长指示管检测法得出的不一致利福平药敏结果
Microb Drug Resist. 2017 Dec;23(8):1045-1052. doi: 10.1089/mdr.2016.0149. Epub 2017 Apr 27.
3
Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
利用数字技术加强结核病防治:范围综述
J Med Internet Res. 2020 Feb 13;22(2):e15727. doi: 10.2196/15727.
4
Genotyping of Mycobacterium tuberculosis Rifampin Resistance-Associated Mutations by Use of Data from Xpert MTB/RIF Ultra Enables Large-Scale Tuberculosis Molecular Epidemiology Studies.Xpert MTB/RIF Ultra 检测数据进行结核分枝杆菌利福平耐药相关基因突变检测,可支持大规模结核病分子流行病学研究。
J Clin Microbiol. 2019 Dec 23;58(1). doi: 10.1128/JCM.01504-19.
5
Bridging the TB data gap: extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.弥合结核病数据差距:从全基因组序列数据中提取耐利福平结核病诊断测试结果
PeerJ. 2019 Aug 26;7:e7564. doi: 10.7717/peerj.7564. eCollection 2019.
6
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.快速检测对检测隐匿性耐利福平结核分枝杆菌 rpoB 突变的可变能力。
Sci Rep. 2019 Aug 14;9(1):11826. doi: 10.1038/s41598-019-48401-z.
7
Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations.Xpert Ultra 能够明确鉴定出特定的利福平耐药性相关突变。
J Clin Microbiol. 2018 Aug 27;56(9). doi: 10.1128/JCM.00686-18. Print 2018 Sep.
南非实施Xpert MTB/RIF后耐多药结核病治疗前的延误和失访:一项回顾性队列研究。
PLoS Med. 2017 Feb 21;14(2):e1002238. doi: 10.1371/journal.pmed.1002238. eCollection 2017 Feb.
4
Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria.在尼日利亚克罗斯河州,使用Xpert MTB/Rif检测结核分枝杆菌的利福平耐药性及rpoB基因突变的81bp利福平耐药决定区。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S145-S146. doi: 10.1016/j.ijmyco.2016.09.007. Epub 2016 Oct 21.
5
Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing.全基因组测序用于广泛耐药和耐多药结核病监测和耐药性检测。
Clin Microbiol Infect. 2017 Mar;23(3):161-166. doi: 10.1016/j.cmi.2016.10.014. Epub 2016 Oct 24.
6
Tuberculosis Diagnostics: State of the Art and Future Directions.结核病诊断:现状与未来方向。
Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0019-2016.
7
Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria.利福平耐药相关 rpoB 基因突变的共识编号系统。
Clin Microbiol Infect. 2017 Mar;23(3):167-172. doi: 10.1016/j.cmi.2016.09.006. Epub 2016 Sep 21.
8
Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases.预防耐多药结核病的传播和保护传染病接触者。
Clin Microbiol Infect. 2017 Mar;23(3):147-153. doi: 10.1016/j.cmi.2016.08.024. Epub 2016 Aug 31.
9
Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.在巴基斯坦开伯尔-普赫图赫瓦省使用Xpert MTB/RIF检测结核分枝杆菌临床分离株rpoB基因81bp利福平耐药决定区的利福平耐药突变:一项回顾性研究
BMC Infect Dis. 2016 Aug 12;16:413. doi: 10.1186/s12879-016-1745-2.
10
Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.诊断技术的连通性:加强监测并加速消除结核病
Int J Tuberc Lung Dis. 2016 Aug;20(8):999-1003. doi: 10.5588/ijtld.16.0015.